Cargando…
A Risk Model for CML Patients with COVID-19: Importance of Molecular Response in the Context of Age, Comorbidities and Country Income
Autores principales: | Radich, Jerald P., Kok, Chung Hoow, Chelysheva, Ekaterina Yu., Cortes, Jorge E., Jiang, Qian, Mauro, Michael, Milojkovic, Dragana, Moiraghi, Beatriz, Nicolini, Franck E., Ongondi, Matilda, Pagnano, Katia B, Žácková, Daniela, Rea, Delphine, Evans, Nicola, Hughes, Timothy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The American Society of Hematology. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9671533/ http://dx.doi.org/10.1182/blood-2022-165855 |
Ejemplares similares
-
COVID-19 in Patients with Chronic Myeloid Leukemia: Poor Outcomes for Patients with Comorbidities, Older Age, Advanced Phase Disease, and Those from Low-Income Countries: An Update of the Candid Study
por: Pagnano, Katia B, et al.
Publicado: (2021) -
COVID-19 in Patients (pts) with Chronic Myeloid Leukemia (CML): Results from the International CML Foundation (iCMLf) CML and COVID-19 (CANDID) Study
por: Rea, Delphine, et al.
Publicado: (2020) -
CML Outcomes and Care Delivery During the COVID-19 Pandemic in Low- and Middle-Income Countries
por: Matsuzaki, Mika, et al.
Publicado: (2023) -
Cytopenia among CML Patients on Imatinib in Kenya: Types, Grades, and Time Course
por: McLigeyo, Angela, et al.
Publicado: (2020) -
The UK SPIRIT 1 trial in newly-diagnosed chronic myeloid leukaemia (CML)
por: Gallipoli, Paolo, et al.
Publicado: (2022)